Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q3 2018 · 10-Q
Revenue$7.87M$7.87M+14.1% vs Q3 2017 Net Income$244.98K$244.98K−62.4% vs Q3 2017 EPS Diluted$0.03$0.03−62.5% vs Q3 2017 Operating Income$920,122−36.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$2,610,854+122.5% Margins · derivedOperating margin11.7%−9.4 pt vs Q3 2017
Net margin3.1%−6.3 pt vs Q3 2017
ended Aug 31, 2018 · filed Oct 15, 2018 · 45 d after period end